Rexulti 4 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F4GB9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,688
Award facts
- Contract value 100% obligated
- $18,687.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 7, 2026, for the supply of Rexulti 4 mg tablets in a 30-count package. The contract, valued at $18,687.70, was awarded without a set-aside designation through open competition and is scheduled for completion by January 8, 2026. This delivery order represents a task order execution under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), an expansive $999.99 billion global pharmaceutical support vehicle through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
As a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, Amerisourcebergen serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems under DLA Medical Supply Chain operations. This specific delivery order for Rexulti, an atypical antipsychotic medication, reflects the company's established capability to fulfill federal requirements for specialty medications across multiple therapeutic domains. The non-set-aside, competitively awarded nature of this task order demonstrates Amerisourcebergen's continued ability to meet federal procurement standards and deliver essential pharmaceutical commodities to support military treatment facilities and government healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26F4GB9?
SPE2DR26F4GB9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F4GB9 worth?
The government has obligated $18,688 on SPE2DR26F4GB9.
Is contract SPE2DR26F4GB9 an order under another contract?
Yes. SPE2DR26F4GB9 is a delivery order under SPE2DR25D3015, an indefinite delivery contract.
Was contract SPE2DR26F4GB9 competed?
The extent of competition for SPE2DR26F4GB9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award